Participants
Prodromal Questionnaire-16
Individuals seeking treatment were eligible for trial inclusion if they were aged 12 to 25 years, met ultrahigh risk criteria,Participants were screened using a standardized clinical assessment and the Prodromal Questionnaire-16 (PQ-16).